{"id":44693,"date":"2020-01-31T00:00:00","date_gmt":"2020-01-30T23:00:00","guid":{"rendered":"https:\/\/techma.bakertilly.es\/sosv-venture-capital-en-el-health-diagnostics\/"},"modified":"2025-03-12T11:49:02","modified_gmt":"2025-03-12T10:49:02","slug":"sosv-venture-capital-en-el-health-diagnostics","status":"publish","type":"post","link":"https:\/\/techma.bakertilly.es\/en\/sosv-venture-capital-en-el-health-diagnostics\/","title":{"rendered":"SOSV: Venture Capital in the Health Diagnostics Sector"},"content":{"rendered":"<p style=\"text-align: justify;\">SOSV is one of the world's leading <a href=\"https:\/\/techma.bakertilly.es\/en\/corporate-venturing\/\">Venture Capital<\/a> into the <em>Health Diagnostics<\/em>with a total of 17 investments since 2013.<\/p>\n<p style=\"text-align: justify;\">Its objective is clear: to acquire shareholding in the sector.<\/p>\n<p style=\"text-align: justify;\">This is clear from the Baker Tilly study.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.bakertilly.es\/\" target=\"_blank\" rel=\"noopener\">Baker Tilly<\/a> has produced a study covering 1733 companies from around the world, labelled within the category \"...\".<em>Diagnostics<\/em>\".<\/p>\n<p style=\"text-align: justify;\">In particular, in the category \"<em>Health Diagnostics<\/em>1043 \"The number of <a href=\"https:\/\/techma.bakertilly.es\/en\/investor-seeking-and-capital-raising\/\">rounds<\/a>and has funds valued at $12.78B.<\/p>\n<p>It is worth noting that due to the characteristics of the sector, Venture Capital firms are common in the sector.<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"TOP_COMPANIES_EN_HEALTH_DIAGNOSTICS\"><\/span>TOP COMPANIES IN HEALTH DIAGNOSTICS<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"ROCHE\"><\/span>ROCHE<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\">It is a Swiss company, <strong>pioneer in providing specific treatments to patients<\/strong>.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.roche.com\/\" target=\"_blank\" rel=\"noopener\">Roche<\/a> provides automated instruments, software, consumables and informatics solutions for in vitro diagnostics and research.<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"BIOMERIEUX\"><\/span>BIOMERIEUX<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.biomerieux.com\/\" target=\"_blank\" rel=\"noopener\">Biomerieux<\/a> is a French company, which <strong>designs, develops, manufactures and markets in vitro diagnostic systems for clinical and industrial applications.<\/strong>.<\/p>\n<p style=\"text-align: justify;\">These include the diagnosis of infectious diseases, cardiovascular diseases and specific cancers.<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"QUIDEL\"><\/span>QUIDEL<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/www.quidel.com\/\" target=\"_blank\" rel=\"noopener\">Quidel<\/a> is an American company <strong>dedicated to the development, manufacturing and commercialisation of diagnostic solutions for <em>POC <\/em>(<em>Ponit of Care<\/em>).<\/strong><\/p>\n<p style=\"text-align: justify;\">In particular, for infectious diseases and women's reproductive health.<\/p>\n<p style=\"text-align: justify;\">In the following, we will analyse <a href=\"https:\/\/sosv.com\/\" target=\"_blank\" rel=\"noopener\">SOSV<\/a>one of the leading investment firms in <em>Venture Capital<\/em> in the sector <em>Health Diagnostics<\/em>.<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"SOSV\"><\/span>SOSV<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align: justify;\">It is a <strong>investment firm of <em>Venture Capital<\/em> which provides multi-stage funding, especially early-stage funding to start-up companies with rounds <em>seed<\/em><\/strong>.<\/p>\n<p style=\"text-align: justify;\">It helps develop and scale great ideas from new founders, through financial and intellectual capital.<\/p>\n<p style=\"text-align: justify;\">To date, SOSV has financed more than 900 start-ups.<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"IDEOLOGIA_Y_VALORES\"><\/span>IDEOLOGY AND VALUES<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align: justify;\">For SOSV, building a better future means empowering the next generation of entrepreneurs.<\/p>\n<p style=\"text-align: justify;\">Only in this way will they be able to solve the major challenges of today's world.<\/p>\n<p style=\"text-align: justify;\">Notably, almost half of the firm's portfolio is aligned with the United Nations Sustainable Development Goals.<\/p>\n<p style=\"text-align: justify;\">In addition, SOSV is proud to be one of the leading investors in companies founded by women.<\/p>\n<p><a href=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/05\/vc1.jpg\"><img decoding=\"async\" class=\"aligncenter wp-image-26306 size-full\" title=\"SOSV: Venture Capital in the Health Diagnostics Sector\" src=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/05\/vc1.jpg\" alt=\"SOSV: Venture Capital in the Health Diagnostics Sector\" width=\"218\" height=\"161\" \/><\/a><a href=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/09\/v2-5.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-26307\" src=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/09\/v2-5.jpg\" alt=\"\" width=\"213\" height=\"159\" title=\"\"><\/a><a href=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/09\/v3-5.jpg\"><img decoding=\"async\" class=\"aligncenter wp-image-26308 size-full\" title=\"SOSV: Venture Capital in the Health Diagnostics Sector\" src=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/09\/v3-5.jpg\" alt=\"SOSV: Venture Capital in the Health Diagnostics Sector\" width=\"212\" height=\"154\" \/><\/a><\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"INVERSIONES_REALIZADAS_EN_EL_SECTOR\"><\/span>INVESTMENTS MADE IN THE SECTOR<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align: justify;\">As can be seen from the data shown above, from 2013 to the recently ended 2019, SOSV has made a total of 25 investments, thanks to which <a href=\"https:\/\/techma.bakertilly.es\/en\/acquiere-a-company-2\/\">has acquired<\/a> numerous actions by companies in the <em>Health Diagnostics<\/em>.<\/p>\n<p style=\"text-align: justify;\">2018 was the most productive year, with 8.<\/p>\n<p style=\"text-align: justify;\">As a good firm of <em>Venture Capital<\/em>Of those, 25 investments, 17 were in the <em>seed<\/em>while the remaining 8 took place in <em>Late Stage<\/em>.<\/p>\n<p>The US is the country that has benefited most from them.<\/p>","protected":false},"excerpt":{"rendered":"<p>Baker Tilly has analysed the Health Diagnostics sector. We analysed SOSV, a major Venture Capital investment firm, to buy shares in it.<\/p>","protected":false},"author":4,"featured_media":44695,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1750],"tags":[152,155,153,172],"sectores":[2214],"tipo-contenido":[2260],"class_list":["post-44693","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-financiacion-sectorial","tag-compra-de-empresas","tag-corporate-finance-spain","tag-global-corporate-finance","tag-venture-capital","sectores-digital-media-advertising","tipo-contenido-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/44693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/comments?post=44693"}],"version-history":[{"count":0,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/44693\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media\/44695"}],"wp:attachment":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media?parent=44693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/categories?post=44693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tags?post=44693"},{"taxonomy":"sectores","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/sectores?post=44693"},{"taxonomy":"tipo-contenido","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tipo-contenido?post=44693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}